On this page
What each program costs in Arizona
The monthly price is all-in: the drug plus a membership when we have verified one. Compounded drugs are not FDA-approved.
| # | Program | Cheapest product | Plan | All in | Membership fee | Trustpilot | Checked | Seller site |
|---|---|---|---|---|---|---|---|---|
| 1 | Compounded Semaglutide | sale price | $39/mo | not verified | too few reviews | Visit | ||
| 2 | Compounded Semaglutide | 12-month plan, $588 up front | $49/mo | none | 3.9 (11,798 reviews) | Visit | ||
| 3 | Compounded Semaglutide | month to month | $59/mo | none | too few reviews | Visit | ||
| 4 | Compounded Semaglutide | 12-month plan, $828 up front | $69/mo | none | 4.6 (4,268 reviews) | Visit | ||
| 5 | Compounded Semaglutide | medication monthly, membership yearly | $75/mo | $199/yr, included | 4.8 (288 reviews) | Visit | ||
| 6 | Compounded Semaglutide | month to month | $79/mo | none | too few reviews | Visit | ||
| 7 | Compounded Semaglutide | month to month | $99/mo | none | 4.6 (5,235 reviews) | Visit | ||
| 8 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.3 (880 reviews) | Visit | ||
| 9 | Compounded Semaglutide | 12-month plan, $1,188 up front | $99/mo | none | 4.2 (218 reviews) | Visit | ||
| 10 | Compounded Semaglutide | 12-month plan, $1,260 up front | $105/mo | none | too few reviews | Visit | ||
| 11 | Compounded Semaglutide | 12-month plan, $1,698 up front | $141/mo | none | too few reviews | Visit | ||
| 12 | Semaglutide | month to month | $149/mo | none | too few reviews | Visit | ||
| 13 | Compounded Semaglutide | 12-month plan, $1,788 up front | $149/mo | none | 4.2 (777 reviews) | Visit | ||
| 14 | Microdosing Tirzepatide | 12-month plan, $2,028 up front | $169/mo | none | 4.0 (162 reviews) | Visit | ||
| 15 | Compounded Semaglutide | 2-month plan, $350 up front | $175/mo | none | 4.6 (1,084 reviews) | Visit | ||
| 16 | Compounded Oral Semaglutide Capsules | 6-month plan, $1,194 up front | $199/mo | none | too few reviews | Visit | ||
| 17 | Foundayo (brand orforglipron) | medication monthly, membership yearly | $208/mo | $59/mo, billed yearly, included | 4.6 (4,607 reviews) | Visit | ||
| 18 | Sublingual Semaglutide | month to month | $249/mo | none | 4.5 (17,622 reviews) | Visit | ||
| 19 | Compounded Semaglutide | month to month | $299/mo | none | too few reviews | Visit |
What do Arizona's big insurers publish on Wegovy and Zepbound?
Blue Cross Blue Shield of Arizona (AZ Blue)
AZ Blue's August 2024 provider notice says GLP-1s approved for type 2 diabetes, such as Ozempic, are covered only for that purpose and not for weight-loss management, across its group and individual plans, from September 1, 2024. The notice does not address Wegovy or Zepbound.
Blue Cross Blue Shield of Arizona
AZ Blue says diabetes-approved GLP-1s are not covered for weight-loss management.
“Note: The GLP-1s approved for the treatment of type 2 diabetes are not covered for weight-loss management.”
https://info.azblue.com/202408-providers-coverage-update-for-glp-1 · read Oct 29, 2026
Blue Cross Blue Shield of Arizona
The rule applies to AZ Blue group plans and its individual and family plans.
“Our GLP-1 coverage guideline revision applies to AZ Blue group plans and all of our plans for individuals and families.”
https://info.azblue.com/202408-providers-coverage-update-for-glp-1 · read Oct 29, 2026
Does Arizona Medicaid (AHCCCS) cover GLP-1s for weight loss?
Wegovy no, Zepbound not confirmed
AHCCCS told an Arizona legislative committee on 13 November 2025 that it does not cover GLP-1 drugs for obesity, and it named Wegovy as covered only in specific circumstances for heart risk; that is the newest agency statement we could read. Read from state documents Nov 6, 2026.
What Arizona Medicaid (AHCCCS)'s documents say about each drug for weight loss. Read Nov 6, 2026. Arizona Health Care Cost Containment System.
WegovyNo
AHCCCS says it covers Wegovy in specific circumstances to reduce heart risk, when medically necessary and with prior authorization. Status as of November 2025.
“AHCCCS currently does not cover GLP-1 for the treatment of obesity.”
AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report · Effective Nov 13, 2025 · read Nov 6, 2026
“AHCCCS also covers 1 GLP-1 Receptor Agonist (Wegovy) in specific circumstances to reduce the risk of major adverse cardiovascular events when medically necessary and approved via prior authorization.”
AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report · Effective Nov 13, 2025 · read Nov 6, 2026
ZepboundUnclear
The AHCCCS statement says GLP-1 is not covered for obesity but does not name Zepbound or tirzepatide, a combined GIP and GLP-1 drug. AHCCCS's own drug list, criteria and policy manual refused our reader (403), so no document settles it for this drug.
OzempicNo
AHCCCS says GLP-1 is not covered for obesity. For type 2 diabetes, members must have a documented failure of non GLP-1 treatment such as metformin. Status as of November 2025.
“AHCCCS currently does not cover GLP-1 for the treatment of obesity.”
AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report · Effective Nov 13, 2025 · read Nov 6, 2026
“For the treatment of type 2 diabetes, members must have a documented failure of non GLP-1 treatments (metformin).”
AHCCCS presentation to the Arizona House Obesity Treatment Study Committee, published in the committee's final report · Effective Nov 13, 2025 · read Nov 6, 2026
MounjaroUnclear
The AHCCCS statement says GLP-1 is not covered for obesity but does not name Mounjaro or tirzepatide, a combined GIP and GLP-1 drug. AHCCCS's own drug list, criteria and policy manual refused our reader (403), so no document settles it for this drug.
This reports what the documents say. It is not medical or legal advice: your plan and your prescriber decide.
What changed, and when
- Nov 6, 2026 · This pageFirst read from Arizona Health Care Cost Containment System documents. KFF's January 2026 map listed this program as not covered; the documents we read answer only part of the question.
Weight loss
Not covered in part, read Nov 2026
Type 2 diabetes
Required in every state
Heart risk, sleep apnea
Required (Wegovy, Zepbound)
Prior authorization
Typical when covered
Wegovy, Zepbound, Saxenda, 2025
865 prescriptions
Ozempic and Mounjaro, 2025
13,100 prescriptions
Neighbours covering weight loss
0 of 5
Federal law lets each state decide whether Medicaid pays for drugs used for weight loss, while drugs approved for diabetes must be covered. A state document may not settle every plan; if your Arizona Medicaid coverage comes through a managed care plan, its formulary can differ, so ask the plan before you fill.
For comparison, a dated secondary source: KFF's January 2026 map listed Arizona Medicaid as "not covered" for GLP-1s for obesity under fee-for-service.
The BALANCE model
CMS’s BALANCE model lets state Medicaid programs add GLP-1s for weight management at a negotiated price. States could join on a rolling basis from May 1, 2026 through January 1, 2027, and the state application deadline was July 31, 2026. We could not find a published list of the states that joined, so this page does not say whether Arizona Medicaid did. Ask your plan. Either way your cost stays at Medicaid’s nominal copay, which BALANCE does not change.
The national picture, coupons and patient assistance: does Medicaid cover GLP-1s.
How many GLP-1s does Arizona Medicaid pay for?
93,519 GLP-1 prescriptions in 2025, 25th of the 50 states and DC, with $93.7 million reimbursed before rebates. Counting the share other payers covered, $98.1 million.
Prescriptions, 2025
93,519
25th of 51
Medicaid paid
$93.7M
23rd of 51, before rebates
Per prescription
$1,002
$1,051 nationally
Weight-loss brands
0.9%
40th highest share of 51
CMS State Drug Utilization Data 2025, updated Jul 13, 2026, fee-for-service and managed care, before rebates. Arizona is highlighted. CMS publishes this comparison as one year, not a trend.
Wegovy, Zepbound and Saxenda, the brands approved for weight management, were 0.9% of Arizona Medicaid's GLP-1 prescriptions in 2025 (865). Across the 13 states KFF lists as covering GLP-1s for obesity, the median share was 52%; across the other 38, 2.3%. Where weight loss is not covered, those brands are mostly filled for the uses Medicaid must cover, such as heart risk and sleep apnea. Trulicity was Arizona Medicaid's most filled GLP-1.
| Brand | Prescriptions | Share | Medicaid paid | Per Rx |
|---|---|---|---|---|
| Trulicity | 74,855 | 80% | $78.9 million | $1,054 |
| Ozempic | 6,974 | 7.5% | $5.9 million | $848 |
| Mounjaro | 6,126 | 6.6% | $5.4 million | $877 |
| Liraglutide (generic) | 2,574 | 2.8% | $1.1 million | $415 |
| Victoza | 1,543 | 1.6% | $997,647 | $647 |
| Wegovyapproved for weight management | 865 | 0.9% | $929,354 | $1,074 |
| Rybelsus | 315 | 0.3% | $285,342 | $906 |
| Byetta | 148 | 0.2% | $120,987 | $817 |
| Exenatide (generic) | 94 | 0.1% | $73,505 | $782 |
| Bydureon | 25 | 0.0% | $19,412 | $776 |
Source: CMS State Drug Utilization Data 2025, updated Jul 13, 2026, all four quarters, fee-for-service and managed care. Before rebates. CMS suppresses rows under 11 prescriptions, so small brands are undercounted slightly. Every state ranked: prescriptions and spending.
Which FDA-registered outsourcing facilities are in Arizona?
FDA's register of 503B outsourcing facilities, updated Nov 17, 2026, lists 2 in Arizona. The register does not say which, if any, supplies a program on this page.
- Central Admixture Pharmacy Services, Phoenix. Registered since Mar 29, 2018; last FDA inspection Sep 5, 2025.
- Tailstorm Health Inc., Chandler. Registered since Oct 23, 2019; last FDA inspection Aug 28, 2026.
On Medicare in Arizona?
Medicare’s temporary GLP-1 Bridge works the same in every state: a $50 copay for a one-month supply of Wegovy, Foundayo or the Zepbound KwikPen, for people with Part D who meet its weight and health rules.
medicare.gov
“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”
https://www.medicare.gov/coverage/weight-loss-drugs · read Nov 14, 2026
Arizona and the states around it
Medicaid’s weight-loss answer (the state’s own documents where we have read them, otherwise KFF, January 2026) and the partner programs that ship there, priced the same way as above.
None of the 5 states next to Arizona covers GLP-1s for weight loss through Medicaid. None has a lower cash floor than Arizona's $39.
| State | Medicaid, weight loss | Ship there | Cheapest that ships there |
|---|---|---|---|
| Arizona | Not covered in part | 19 | $39/mo |
| California | Not covered | 17 | $39/moWellmedr |
| Colorado | Not covered | 19 | $39/moWellmedr |
| Nevada | Not covered | 19 | $39/moWellmedr |
| New Mexico | Not covered | 19 | $39/moWellmedr |
| Utah | Not confirmed | 19 | $39/moWellmedr |






















